{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:24:01Z","timestamp":1792513441615,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.aohep.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T12:08:16Z","timestamp":1569413296000},"page":"816-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure"],"prefix":"10.1016","volume":"18","author":[{"given":"\u00c9rica Ara\u00fajo","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Regina Bairros de","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catharina de Seixas","family":"Santos Nastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda de Mello","family":"Malta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno dos Santos","family":"Pascoalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Augusto","family":"Carneiro D\u2019Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Lucio Holanda Gondim de","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison Luis","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flair Jos\u00e9","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Renato","family":"Rebello Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.09.001_bib0175","first-page":"442","article-title":"Yellow fever in Africa and the Americas, 2016","volume":"92","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.aohep.2019.09.001_bib0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.aohep.2019.09.001_bib0185","first-page":"91","article-title":"The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling","author":"Best","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0190","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2014.02.006","article-title":"Polymerases of hepatitis C viruses and flaviviruses: structural and mechanistic insights and drug development","volume":"105","author":"Caillet-Saguy","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature22401","article-title":"Establishment and cryptic transmission of Zika virus in Brazil and the Americas","volume":"546","author":"Faria","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2019.09.001_bib0205","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pntd.0002636","article-title":"Molecular evolution of Zika virus during its emergence in the 20(th) century","volume":"8","author":"Faye","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0210","doi-asserted-by":"crossref","first-page":"e7072","DOI":"10.1371\/journal.pntd.0007072","article-title":"Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo","volume":"13","author":"Freitas","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2019.09.001_bib0220","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cid\/cit074","article-title":"What the infectious disease physician needs to know about pegylated interferon and ribavirin","volume":"56","author":"Gara","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bjid.2017.02.004","article-title":"Yellow fever outbreak in Brazil, 2017","volume":"21","author":"Goldani","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhin.2016.11.012","article-title":"Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients","volume":"95","author":"Gorcea","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.aohep.2019.09.001_bib0235","first-page":"256","article-title":"Ledipasvir\/Sofosbuvir (harvoni): improving options for hepatitis C virus infection","volume":"40","author":"Gritsenko","year":"2015","journal-title":"P T"},{"key":"10.1016\/j.aohep.2019.09.001_bib0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.aohep.2019.09.001_bib0245","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(16)30513-8","article-title":"Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015\u201316: a modelling study","volume":"17","author":"Kraemer","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"Julander","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0255","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0265","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.01360-09","article-title":"Identification of hepatitis C virus NS5A inhibitors","volume":"84","author":"Lemm","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/mol.105.020057","article-title":"The anti-yellow fever virus activity of ribavirin is independent of error-prone replication","volume":"69","author":"Leyssen","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0275","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc15d02s27","article-title":"Dengue virus: isolation, propagation, quantification, and storage","author":"Medina","year":"2012","journal-title":"Curr Protoc Microbiol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0280","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.12688\/f1000research.9648.1","article-title":"Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library","volume":"5","author":"Pascoalino","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.aohep.2019.09.001_bib0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0295","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.aohep.2019.09.001_bib0300","doi-asserted-by":"crossref","first-page":"e190033","DOI":"10.1590\/0074-02760190033","article-title":"Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases","volume":"114","author":"Casadio","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.aohep.2019.09.001_bib0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jmbi.2000.4042","article-title":"T-Coffee: a novel method for fast and accurate multiple sequence alignment","volume":"302","author":"Notredame","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.aohep.2019.09.001_bib0310","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.09.001_bib0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.27826","article-title":"Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis","volume":"62","author":"Reddy","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.09.001_bib0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2016.12.011","article-title":"Sofosbuvir: an antiviral drug with potential efficacy against Zika infection","volume":"55","author":"Reznik","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.001_bib0325","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2019.09.001_bib0330","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1111\/hepr.12971","article-title":"Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin","volume":"48","author":"Sato","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2019.09.001_bib0335","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3851\/IMP2733","article-title":"Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938","volume":"19","author":"Guedj","year":"2014","journal-title":"Antivir Ther"},{"issue":"May","key":"10.1016\/j.aohep.2019.09.001_bib0340","article-title":"Yellow fever and orthotopic liver transplantation: new insights from the autopsy room for an old but re-emerging disease","author":"Duarte-Neto","year":"2019","journal-title":"Histopathology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:31Z","timestamp":1761647971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119322434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1665268119322434"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.001","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}